Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023

SELL
$31.15 - $33.39 $903 - $968
-29 Reduced 59.18%
20 $0
Q3 2022

Nov 08, 2022

SELL
$30.9 - $33.55 $185 - $201
-6 Reduced 10.91%
49 $2,000
Q2 2022

Aug 10, 2022

SELL
$23.75 - $31.69 $427 - $570
-18 Reduced 24.66%
55 $2,000
Q1 2022

May 02, 2022

SELL
$19.97 - $26.94 $459 - $619
-23 Reduced 23.96%
73 $2,000
Q4 2021

Jan 25, 2022

BUY
$17.46 - $21.61 $1,309 - $1,620
75 Added 357.14%
96 $2,000
Q3 2021

Oct 28, 2021

BUY
$17.35 - $22.5 $364 - $472
21 New
21 $0
Q2 2021

Jul 26, 2021

SELL
$18.01 - $28.32 $2,125 - $3,341
-118 Closed
0 $0
Q2 2020

Jul 30, 2020

BUY
$7.84 - $23.29 $925 - $2,748
118 New
118 $3,000
Q1 2020

Apr 23, 2020

SELL
$5.57 - $11.5 $595 - $1,230
-107 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$7.9 - $10.14 $845 - $1,084
107 New
107 $1,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.